Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Approval times and the safety of new pharmaceuticalsNiklas RudholmHealth Policy (Amsterdam, Netherlands)|November 11, 2005
A comparison of population versus individual based cardiovascular disease prevention programs in Västerbotten, SwedenNiklas RudholmJournal of Health Economics|December 12, 2002
Economic implications of antibiotic resistance in a global economyNiklas RudholmHealth Policy (Amsterdam, Netherlands)|January 1, 2008
Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availabilityNiklas RudholmScandinavian Journal of Public Health|March 15, 2005
Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, SwedenNiklas RudholmThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 17, 2005
Side effects of generic competition?Jörgen Hellström, Niklas RudholmThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 26, 2006
Fixed budgets as a cost containment measure for pharmaceuticalsDavid Granlund, Niklas Rudholm, Magnus WikströmInternational Journal of Health Economics and Management|November 24, 2016
Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily doseMats A Bergman, David Granlund, Niklas RudholmHealth Policy (Amsterdam, Netherlands)|November 18, 2005
Does "the injury poverty trap" exist? A longitudinal study in Bavi, VietnamNguyen Xuan Thanh, Hoang Minh Hang, Nguyen Thi Kim Chuc, et al.Pageof 1